📄 Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses.

Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human Co. Vs.

keywords 🔗 MERS-CoV (691) 🔗 SARS-CoV (1685) 🔗 SARS-CoV-2 (551) 🔗 human coronaviruses (166) 🔗 neutralizing antibodies (122) 🔗 severe acute (1373) 🔗 public health (392) 🔗 neutralizing antibodies (122) 🔗 respiratory syndrome (2004) 🔗 acute respiratory (1734)

download 🔖 [BibTeX]